mounjaro eye disorder

The quick read

What's driving the attention

Australian health authorities warned of serious eye disorders linked to GLP-1 drugs like Mounjaro and Ozempic, raising public concern.

The Australian Therapeutic Goods Administration has issued warnings about a rare but severe eye disorder associated with GLP-1 receptor agonist medications such as Ozempic, Wegovy, and Mounjaro. These warnings highlight risks including potential blindness and hair loss as noted by multiple news outlets. Public interest in this health warning has surged by 600%, reflecting growing concern and the need to understand the side effects of these diabetes and weight-loss drugs.